Scribe
Scribe develops an AI-powered platform that automatically generates step-by-step guides with text and screenshots to document business processes.
Secondary Market Price
Secondary Market Price
How Scribe Measures Up
To help you manage your Scribe equity, Prospect has run the company through our machine learning model.
Prospect Rating
4X
Our rating for Scribe projects a potential 4X increase in its value over the next four years. For an employee with stock options, this suggests your equity could see a similar increase in value if the company hits that target.
Exit Risk
High Risk
Our High Risk rating for Scribe is based on its focus on a nascent but large market, which presents a greater likelihood of the company not reaching a liquidity event for employees when compared to startups in more established industries.
Funding Stage
Series B
Scribe's Series B status means it's a more established company with a proven product, offering greater stability than a brand-new startup. This gives you the chance to join a structured environment that still has plenty of room for you to make an impact and grow your career.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of Scribe's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future Scribe Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Scribe's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
Scribe is a technology company that develops an artificial intelligence-powered platform designed to automate process documentation. The software captures a user's workflow on their screen and automatically generates a step-by-step guide, including both text instructions and screenshots. These guides are used for purposes such as creating training materials, onboarding new employees, and developing customer-facing help centers. Founded in 2019 and headquartered in San Francisco, the company was previously known as Cursive and Colony Labs. It has seen significant adoption, with users at organizations like LinkedIn, HubSpot, and T-Mobile.
The company is currently focused on expansion, which is supported by a recent Series B funding round that raised $25 million on February 15, 2024, resulting in a company valuation of $220 million. This investment is fueling growth, evidenced by active hiring across multiple departments including software engineering, sales, and product management. Scribe has also made recent additions to its leadership team, such as a new VP of Engineering, as it works to scale its operations and continue developing its platform for automated internal knowledge capture.
- Tiger Global
- Redpoint
- Amplify Partners
- XYZ
- New York Life
- Co-Founder, CEO Jennifer Smith
- Co-Founder, CTO Aaron Podolny
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is Scribe worth joining?
Scribe is a growing Series B startup in the AI/ML space with a recent valuation of $220 million. To determine if it's the right fit for you, you can use a platform like Prospect to analyze its potential and compare it to other top startups.
What should I do with my Scribe stock?
Since Scribe is a private company, managing your equity involves understanding its potential value and tax implications. Platforms like Prospect provide tools to help you create personalized strategies for your stock options, including when to exercise and how to optimize for taxes.
Can you sell Scribe stock?
As a private company, Scribe stock is not traded on public markets like the NYSE or NASDAQ. Selling private shares is typically possible only during specific liquidity events, such as a tender offer or acquisition.
How can I find the value of my Scribe stock?
The per-share value of private stock isn't publicly available and is determined by the company's 409A valuation. You can use platforms like Prospect, which leverage VC-grade data and predictive models, to get an independent projection of what your Scribe equity might be worth.
What is Scribe's equity worth?
Scribe's most recent company valuation is $220 million, based on its Series B funding round in February 2024. To understand what your specific equity stake could be worth under different scenarios, you can use an equity calculator to model potential outcomes.
What is Scribe's stock ticker symbol?
Scribe does not have a stock ticker symbol because it is a private company. Ticker symbols are only assigned to companies whose shares are traded on a public stock exchange.
Can I buy or sell Scribe stock?
Scribe stock is not available for purchase on public markets, and buying shares is generally restricted to accredited investors during specific funding rounds. Selling is also limited, typically occurring during company-approved secondary transactions or tender offers.
What is the criteria to buy or invest in Scribe stock?
Investing in a private company like Scribe is typically limited to institutional investors and venture capital firms that participate in its funding rounds. There are no publicly available criteria for individual investors to buy stock at this stage.
